Mark Hiatt

Mark Hiatt possesses extensive experience in healthcare leadership and strategy, currently serving as Senior Vice President of Market Access and Strategy at BostonGene, focusing on AI-based solutions for cancer treatment. Concurrently, Mark holds roles as Chief Medical Officer and Vice President of Clinical Applications at FrontRunnerHC, Chief Medical Officer at RadSite, Chief Medical and Commercial Officer at Bioada, and Strategic Advisor at Optum. As the founder and CEO of Hiatt Advisory Services, Mark has been instrumental in helping clients navigate the healthcare landscape. Previous experience includes Vice President of Medical Affairs at Guardant Health, where significant advancements in precision oncology were achieved, and Executive Medical Director at Regence BlueCross BlueShield, overseeing clinical initiatives for millions of members. Mark's educational background includes multiple degrees from prestigious institutions, culminating in clinical and executive qualifications in healthcare management and informatics.